XPA, XPC, and XPD Modulate Sensitivity in Gastric Cisplatin Resistance Cancer Cells

Cisplatin is an election drug widely used in clinic for the treatment of advanced gastric cancer. However, the heterogeneity of the gastric tumors and its resistance to the drugs, make in some cases the response very low and the prognosis unpredictable. In this manuscript we aim to find the molecula...

Descripción completa

Detalles Bibliográficos
Autores principales: Pajuelo-Lozano, Natalia, Bargiela-Iparraguirre, Jone, Dominguez, Gemma, Quiroga, Adoracion G., Perona, Rosario, Sanchez-Perez, Isabel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6199368/
https://www.ncbi.nlm.nih.gov/pubmed/30386247
http://dx.doi.org/10.3389/fphar.2018.01197

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6199368/
https://www.ncbi.nlm.nih.gov/pubmed/30386247
http://dx.doi.org/10.3389/fphar.2018.01197

Ejemplares similares